Investor Relations

SEC Filings

Document Details

Form
Filing Date
Jan 19, 2022
Document Date
Jan 17, 2022
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.